cached image

Ashwin Unnikrishnan, Ph.D.

Affiliations: 
2000-2003 Washington University, Saint Louis, St. Louis, MO 
 2004-2009 Basic Sciences Division Fred Hutchinson Cancer Research Center, Seattle, WA, United States 
 2011- Lowy Cancer Research Centre University of New South Wales, Kensington, New South Wales, Australia 
Area:
Molecular Biology, Biochemistry, Cell Biology, Hematopoietic Cancers
Website:
https://powcs.med.unsw.edu.au/node/301300772
Google:
""Ashwin Unnikrishan" + Sydney"
Bio:

I am a biomedical research scientist and Head of the Molecular Mechanisms in Leukaemia laboratory at the Lowy Cancer Research Centre, University of New South Wales.

My lab's research interests in haematological cancers and Myelodysplastic Syndrome (MDS) in particular. We use a combination of genomics, epigenomics, molecular biology and stem cell biology techniques to understand the molecular mechanisms driving leukaemia, as well as that underpinning response to therapy.

I received my Ph.D. in Molecular & Cellular Biology from the Fred Hutchinson Cancer Research Center and the University of Washington (U.S.A.) in 2009, and my A.B., Magna cum laude, in Biochemistry and Molecular Biology from Washington University in St. Louis (U.S.A.) in 2003.

Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Toshio Tsukiyama grad student 2004-2009 Fred Hutchinson Cancer Center
 (PhD Thesis: The role of histone modifications in DNA replication.)
John Pimanda post-doc 2011-2018 University of New South Wales
Gary Stormo research scientist 2001-2001 Washington University School of Medicine (Computational Biology Tree)
 (Undergraduate research)
Eduardo A. Groisman research scientist 2001-2003 Washington University School of Medicine
 (Undergraduate research)
Craig S. Pikaard research scientist 2003-2004 Washington University (Cell Biology Tree)
 (Undergraduate research)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schnegg-Kaufmann AS, Thoms JAI, Bhuyan GS, et al. (2022) Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy. Blood
Saini SK, Holmberg-Thydén S, Bjerregaard AM, et al. (2022) Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies. Leukemia. 36: 2734-2738
John Newton Amaldoss M, Pandzic E, Koshy P, et al. (2022) Detection and Quantification of Nanoparticle-Induced Intracellular ROS in Live Cells by Laser Scanning Confocal Microscopy. Methods (San Diego, Calif.)
Chandrakanthan V, Rorimpandey P, Zanini F, et al. (2022) Mesoderm-derived PDGFRA cells regulate the emergence of hematopoietic stem cells in the dorsal aorta. Nature Cell Biology
Liu L, Vujovic A, Deshpande NP, et al. (2022) The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors. Nature Communications. 13: 3833
Amaldoss MJN, Mehmood R, Yang JL, et al. (2022) Anticancer therapeutic effect of cerium-based nanoparticles: known and unknown molecular mechanisms. Biomaterials Science
Liu YC, Kwon J, Fabiani E, et al. (2022) Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy. The New England Journal of Medicine. 386: 1998-2010
Yang J, Gao C, Liu M, et al. (2021) Targeting an inducible SALL4-mediated cancer vulnerability with sequential therapy. Cancer Research
Lorenzi L, Chiu HS, Avila Cobos F, et al. (2021) Publisher Correction: The RNA Atlas expands the catalog of human non-coding RNAs. Nature Biotechnology
Lorenzi L, Chiu HS, Avila Cobos F, et al. (2021) The RNA Atlas expands the catalog of human non-coding RNAs. Nature Biotechnology
See more...